Evonik to enhance the exclusive sales and distribution of ProPhorce™ SR 130 for the Indian subcontinent
- Expansion of sales and distribution of ProPhorce™ SR 130 from sub-Saharan Africa to the Indian subcontinent
- Butyric acid product complements Evonik’s gut health portfolio
- Announcement comes following R&D collaboration between Perstorp and Evonik
To further strengthen the partnership between Evonik and Swedish manufacturer, Perstorp, the sales and distribution of ProPhorce™ SR 130 have been expanded to the Indian subcontinent: India, Nepal, Sri Lanka, Bangladesh and Pakistan. The move follows the announcement in May of Evonik’s exclusive distribution of the product in sub-Saharan Africa. The latest development will intensify the sales, marketing and distribution of the product in the new target markets.
ProPhorce™ SR 130 is a butyric acid product that is a safe, easy to handle and cost-efficient solution for in-feed application in livestock management. Butyric acid is a key ingredient for optimal digestion as it favours gut wall integrity which is important for performance. The product complements the mode of action of Evonik’s probiotics and shows beneficial effects that can bring added value to customers when the products are used together.
There are many similarities between human gut health and condition and that of animals like chickens. To highlight bacterial cells’ impact on the body of both species, the two companies hosted a webinar themed as “Let Food and Feed be thy Cure” on July 16, 2020. Almost 300 Evonik customers in the region participated.
The participants received valuable insights from a world-renowned and eminent poultry expert and veterinarian poultry consultant, Dr. Marteen De Gussem. In his presentation, Dr. De Gussem highlighted the vicious circle of gut health and the importance of impact assessment and solution selection to cost effectively manage gut health.
Attendees who participated in the quiz after the webinar had the chance to win a copy of Dr. Gussem’s bestselling practical guide to broiler focused management, “Broiler Signal” as an e-book.
“This partnership will help us to offer a full gut health portfolio in the region” said, Dr. Shreedhar Patel, Vice President for Evonik Animal Nutrition in Asia Pacific South region.
Dr. Saikat Saha, Regional Business Director for Evonik Animal Nutrition for India, Bangladesh, Nepal, Sri Lanka & Myanmar added, “In our continuous effort to provide our customers more value-based solutions, this partnership enables us to bring another unique opportunity aimed at resolving chicken gut health related issues more efficiently in the Indian subcontinent.”
“ProPhorce™ SR 130 is a unique gut health product with unrivalled butyric acid power because of its special formula and advanced esterification technology. It will reach more customers and create more value for the livestock industry in the Indian subcontinent through our distribution partnership with Evonik,” said Jim Ren, Vice President for Perstorp Animal Nutrition for Asia Pacific.
Butyric acid’s activities are well researched and go beyond simple manipulation of gut pH. Butyric acid has been shown to improve pathogen control, provide energy for cells lining the gut wall, enhance secretion of enzymes and improve intestinal cell proliferation, differentiation, and maturation.
All of these attributes mean that ProPhorce™ SR 130 has great potential to assist animal producers in reducing the impact of enteric challenges; in maximizing utilization of the nutrients provided in feeds; and both improving animal welfare and reducing environmental impact.
Company information Evonik
Evonik is one of the world leaders in specialty chemicals. The company is active in more than 100 countries around the world and generated sales of €13.1 billion and an operating profit (adjusted EBITDA) of €2.15 billion in 2019. Evonik goes far beyond chemistry to create innovative, profitable and sustainable solutions for customers. More than 32,000 employees work together for a common purpose: We want to improve life, day by day.
About Nutrition & Care
The focus of the business of the Nutrition & Care division is on health and quality of life. It develops differentiated solutions for active pharmaceutical ingredients, medical devices, nutrition for humans and animals, personal care, cosmetics, and household cleaning. In these resilient end markets, the division generated sales of around €2.92 billion in 2019 with about 5,300 employees. It is part of Evonik Operations GmbH.
Company information Perstorp
Perstorp believes in improving everyday life – making it safer, more convenient and more environmentally sound for billions of people all over the world. As a world leading specialty chemicals company, our innovations provide essential properties for products used every day and everywhere. You’ll find us all the way from your car and mobile phone to towering wind turbines and the local dairy farm. Simply put, we work to make good products even better, with a clear sustainability agenda.
Founded in Sweden in 1881, Perstorp’s focused innovation builds on more than 135 years of experience, representing a complete chain of solutions in organic chemistry, process technology and application development. Perstorp has approximately 1,350 employees and manufacturing units in Asia, Europe and North America. Sales in 2019 amounted to 11.6 billion SEK.
About Perstorp Animal Nutrition
Perstorp has been involved with developing a range of highly effective additives for the agricultural industry for nearly 60 years. As a producer of key raw materials such as propionic, formic, butyric and valeric acid, we focus our efforts on organic acid-based solutions for gut health and preservation and take pride in being the first to provide you with the next generation of acid-based products. Perstorp Animal Nutrition consists of a dedicated team of agricultural specialists within Perstorp that are committed to delivering optimal solutions and service.
Learn more at www.perstorp.com
Disclaimer
In so far as forecasts or expectations are expressed in this press release or where our statements concern the future, these forecasts, expectations or statements may involve known or unknown risks and uncertainties. Actual results or developments may vary, depending on changes in the operating environment. Neither Evonik Industries AG nor its group companies assume an obligation to update the forecasts, expectations or statements contained in this release.